bioAffinity Technologies, Inc. 8-K

What Happened
On June 16, 2026, bioAffinity Technologies, Inc. (BIAF) filed a Form 8-K to announce a press release about an upcoming webinar scheduled for July 21, 2026. The webinar will feature clinical experts discussing emerging approaches to lung health screening and early detection for veterans at increased risk for lung cancer and other respiratory diseases. The press release is included as Exhibit 99.1 to the filing.

Key Details

• Press release and 8-K filed on June 16, 2026.
• Webinar date: July 21, 2026.
• Topic: lung health screening and early detection, with a focus on veterans at increased risk for lung cancer and other respiratory diseases.
• Press release attached as Exhibit 99.1 to the Form 8-K.

Why It Matters
This filing signals bioAffinity's public outreach on lung screening and early detection — areas related to the company’s focus on respiratory diagnostics. For investors, the webinar may increase visibility among clinicians, veterans’ health communities, and potential partners, but the 8‑K does not report any financial results, product launches, regulatory approvals, or binding partnerships.